Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous Terlipressin for Refractory Ascites
NCT03107091Phase 2Completed
- Sponsor
- BioVie
- Start
- Jul 2017
- Primary completion
- Apr 2019
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of terlipressin in ascites, sponsored by BioVie. Started Jul 2017; status: completed.
02
Drugs
terlipressin
03
Conditions
ascites
Beyond the preview
Go deeper on NCT03107091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03107091.